{
  "resourceType": "MedicationStatement",
  "id": "medication-tamoxifen",
  "status": "active",
  "medicationCodeableConcept": {
    "coding": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code": "10324",
        "display": "Tamoxifen"
      }
    ],
    "text": "Tamoxifen"
  },
  "subject": {
    "reference": "Patient/patient-002",
    "display": "Michelle Anne Thompson"
  },
  "effectivePeriod": {
    "start": "2025-08-01"
  },
  "dateAsserted": "2025-08-01",
  "informationSource": {
    "display": "Dr. Oncologist"
  },
  "reasonReference": [
    {
      "reference": "Condition/condition-breast-cancer"
    }
  ],
  "note": [
    {
      "text": "Adjuvant endocrine therapy for ER-positive breast cancer. Planned duration: 5-10 years. Currently on treatment with good tolerance."
    }
  ],
  "dosage": [
    {
      "text": "20 mg PO daily",
      "timing": {
        "repeat": {
          "frequency": 1,
          "period": 1,
          "periodUnit": "d"
        }
      },
      "route": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "26643006",
            "display": "Oral route"
          }
        ]
      },
      "doseAndRate": [
        {
          "doseQuantity": {
            "value": 20,
            "unit": "mg",
            "system": "http://unitsofmeasure.org",
            "code": "mg"
          }
        }
      ]
    }
  ]
}
